| Nature of glutamate alterations in schizophrenia: a meta-analysis of proton magnetic resonance spectroscopy studies K Merritt, A Egerton, MJ Kempton, MJ Taylor, PK McGuire JAMA psychiatry 73 (7), 665-674, 2016 | 398 | 2016 |
| Response to initial antipsychotic treatment in first episode psychosis is related to anterior cingulate glutamate levels: a multicentre 1H-MRS study (OPTiMiSE) A Egerton, BV Broberg, N Van Haren, K Merritt, GJ Barker, DJ Lythgoe, ... Molecular psychiatry 23 (11), 2145-2155, 2018 | 133 | 2018 |
| Relationship between glutamate dysfunction and symptoms and cognitive function in psychosis K Merritt, P McGuire, A Egerton Frontiers in psychiatry 4, 2013 | 129 | 2013 |
| Relationship between brain glutamate levels and clinical outcome in individuals at ultra high risk of psychosis A Egerton, JM Stone, CA Chaddock, GJ Barker, I Bonoldi, RM Howard, ... Neuropsychopharmacology 39 (12), 2891-2899, 2014 | 103 | 2014 |
| Association of age, antipsychotic medication, and symptom severity in schizophrenia with proton magnetic resonance spectroscopy brain glutamate level: a mega-analysis of … K Merritt, PK McGuire, A Egerton, A Aleman, W Block, OJN Bloemen, ... JAMA psychiatry 78 (6), 667-681, 2021 | 95 | 2021 |
| Effects of Antipsychotic Administration on Brain Glutamate in Schizophrenia: A Systematic Review of Longitudinal 1H-MRS Studies A Egerton, A Bhachu, K Merritt, G McQueen, A Szulc, P McGuire Frontiers in psychiatry 8, 66, 2017 | 93 | 2017 |
| Towards precision medicine in psychosis: benefits and challenges of multimodal multicenter studies—PSYSCAN: translating neuroimaging findings from research into clinical practice S Tognin, HH van Hell, K Merritt, I Winter-van Rossum, MG Bossong, ... Schizophrenia bulletin 46 (2), 432-441, 2020 | 78 | 2020 |
| Longitudinal structural MRI findings in individuals at genetic and clinical high risk for psychosis: a systematic review K Merritt, P Luque Laguna, A Irfan, AS David Frontiers in psychiatry 12, 620401, 2021 | 47 | 2021 |
| Dopamine and glutamate in individuals at high risk for psychosis: a meta‐analysis of in vivo imaging findings and their variability compared to controls RA McCutcheon, K Merritt, OD Howes World Psychiatry 20 (3), 405-416, 2021 | 41 | 2021 |
| Variability and magnitude of brain glutamate levels in schizophrenia: a meta and mega-analysis K Merritt, RA McCutcheon, A Aleman, S Ashley, K Beck, W Block, ... Molecular psychiatry 28 (5), 2039-2048, 2023 | 37 | 2023 |
| The Sander parallelogram illusion dissociates action and perception despite control for the litany of past confounds RL Whitwell, MA Goodale, KE Merritt, JT Enns Cortex 98, 163-176, 2018 | 33 | 2018 |
| Remission from antipsychotic treatment in first episode psychosis related to longitudinal changes in brain glutamate K Merritt, R Perez-Iglesias, KV Sendt, R Goozee, S Jauhar, F Pepper, ... NPJ schizophrenia 5 (1), 12, 2019 | 31 | 2019 |
| Symptom remission and brain cortical networks at first clinical presentation of psychosis: the OPTiMiSE study P Dazzan, AJ Lawrence, AATS Reinders, A Egerton, NEM Van Haren, ... Schizophrenia bulletin 47 (2), 444-455, 2021 | 9 | 2021 |
| Glyceryl trinitrate in first-episode psychosis unmedicated with antipsychotics: A randomised controlled pilot study K Merritt, A Catalan, S Cowley, A Demjaha, M Taylor, P McGuire, ... Journal of Psychopharmacology 34 (8), 839-847, 2020 | 7 | 2020 |
| Exploring causal mechanisms of psychosis risk D Oliver, E Chesney, AE Cullen, C Davies, A Englund, G Gifford, S Kerins, ... Neuroscience & Biobehavioral Reviews, 105699, 2024 | 5 | 2024 |
| The impact of cumulative obstetric complications and childhood trauma on brain volume in young people with psychotic experiences K Merritt, P Luque Laguna, A Sethi, M Drakesmith, SA Ashley, ... Molecular Psychiatry 28 (9), 3688-3697, 2023 | 5 | 2023 |
| Molecular and micro-architectural mapping of gray matter alterations in psychosis N García-San-Martín, RAI Bethlehem, A Mihalik, J Seidlitz, I Sebenius, ... Molecular Psychiatry, 1-10, 2024 | 2 | 2024 |
| Identifying electroencephalography biomarkers in individuals at clinical high risk for psychosis in an international multi-site study S Kerins, J Nottage, G Salazar de Pablo, MJ Kempton, S Tognin, ... Frontiers in psychiatry 13, 828376, 2022 | 2 | 2022 |
| Brain glutamate levels and antipsychotic response in schizophrenia A Egerton European Psychiatry 33 (S1), S19-S19, 2016 | 2 | 2016 |
| 165. Nature of Glutamate Alterations in Schizophrenia: A Meta-Analysis of Proton Magnetic Resonance Spectroscopy Studies K Merritt, A Egerton Schizophrenia Bulletin 43 (Suppl 1), S84, 2017 | 1 | 2017 |
James M StoneBrighton and Sussex Medical School; University of Sussex; University of BrightonVerified email at bsms.ac.uk